Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa: Anthropometric and dietary profile

Citation
A. Dannhauser et al., Nutritional status of HIV-1 seropositive patients in the Free State Province of South Africa: Anthropometric and dietary profile, EUR J CL N, 53(3), 1999, pp. 165-173
Citations number
65
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
EUROPEAN JOURNAL OF CLINICAL NUTRITION
ISSN journal
09543007 → ACNP
Volume
53
Issue
3
Year of publication
1999
Pages
165 - 173
Database
ISI
SICI code
0954-3007(199903)53:3<165:NSOHSP>2.0.ZU;2-9
Abstract
Objective: To evaluate the nutritional intake and status of HIV-1 seroposit ive patients, as well as the relationship between malnutrition and disease stage. Design: A cross-sectional study. Settings: The Immunology Clinic at the Pelonomi Hospital in Bloemfontein, S outh Africa. Subjects: Eighty-one HIV/AIDS patients in different stages of disease were recruited consecutively from January to May 1995. Eleven of these patients were followed in 1997. Main outcome measures: Anthropometric data including current weight, height , triceps skinfold thickness, mid-upper-arm circumference, body mass index and bone-free arm muscle area were collected. Nutrient intake was estimated using a diet history in combination with a standardised food frequency que stionnaire. The patients were divided into 3 groups according to their CD4( +) T cell counts. Results: The men were leaner (BMI = 18.9) than the women (BMI = 22.7) and p atients with a CD4+ T cell count < 200 (stage III) tended to have the lowes t median values for all anthropometric measurements. More than half the pat ients had a low intake (< 67% of the recommended dietary allowances) of vit amin C, vitamin B-6, vitamin D, Vitamin A, calcium, iron and zinc. Conclusions: The results confirms that HIV/AIDS patients from this populati on are malnourished There was, however, no association between disease stag e and nutritional status. Nutritional supplementation of HIV/AIDS patients should be considered, as this might lead to improved immune function in the se patients.